✦ LIBER ✦

186 Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma

✍ Scribed by C. Li; M. Iida; E.F. Dunn; T.M. Brand; C.R. Peet; D.L. Wheeler

Book ID: 119602867
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 44 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)71891-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib blocks cetuximab- and radiatio

Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma

✍ Chunrong Li; Mari Iida; Emily F. Dunn; Deric L. Wheeler 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 922 KB

Nuclear epidermal growth factor receptor

Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma

✍ Husain, Hatim; Psyrri, Amanda; Markovic, Ana; Rampias, Theodore; Pectasides, Eir 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Autocrine epidermal growth factor recept

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines

✍ Goro Oshima; Johan Wennerberg; Takashi Yamatodani; Elisabeth Kjellén; Hiroyuki M 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 328 KB

The role of epidermal growth factor rece

The role of epidermal growth factor receptor in head and neck squamous cell carcinoma

✍ Rebecca G. Pomerantz; Jennifer Rubin Grandis 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 537 KB

Radiolabeled cetuximab: Dose optimizatio

Radiolabeled cetuximab: Dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model

✍ Bianca A.W. Hoeben; Janneke D.M. Molkenboer-Kuenen; Wim J.G. Oyen; Wenny J.M. Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head‐and‐neck squamous cell carcinoma could be of value to select patients for EGFR‐targeted therapy. We assessed dose optimization of ^111^Indium‐DTPA‐cetuximab (^111^In‐cetuximab) for EGFR imaging in a head‐and‐neck

Epidermal growth factor receptor targete

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR